Sun Pharmaceutical Industries on Friday said that its subsidiary Taro Pharmaceutical USA resolved all cases involving the company in connection with the multi-year investigations by the Department of Justice, Antitrust Division and Civil Division (DOJ) into the US generic pharmaceutical industry.
No comments:
Post a Comment